Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A5760 KRN 633Summary: VEGFR inhibitor,ATP-competitive
-
A8313 RAF265Target: Raf|VEGFRSummary: Multiple intracellular kinases inhibitor
-
A8347 Pazopanib HydrochlorideSummary: VEGFR/PDGFR/FGFR/c-Kit/ c-Fms inhibitor
-
A8370 Axitinib (AG 013736)1 CitationTarget: VEGFR|PDGFR|c-KitSummary: VEGFR1/ c-Kit inhibitor
-
A8418 Dovitinib Dilactic acidSummary: FLT3 inhibitor
-
A8550 Telatinib (BAY 57-9352)Target: VEGFR|PDGFR|c-KitSummary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor
-
A8555 Vandetanib (ZD6474)Target: VEGFR|EGFRSummary: VEGFR2/EGFR antagonist
-
B1305 SKLB1002Summary: VEGFR2 inhibitor,potent and ATP-competitve
-
B2173 CP-673451Target: PDGFRSummary: PDGFRα/β inhibitor,potent and selective
-
B2303 Apatinib1 CitationSummary: VEGFR2 inhibitor, orally bioavailable, selective